Live Breaking News & Updates on Clin Gastroenterol Hepatol

Stay updated with breaking news from Clin gastroenterol hepatol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis | Company Announcement
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

United States , France General , United Kingdom , Hong Kong , Ipsen Euronext , Clin Gastroenterol Hepatol , Carol Roberts , Christelle Huguet , Anna Gibbins , Ipsen Iqirvo , Rachel Reiff , Kris Kowdley , Nicolas Bogler , Amy Wolf , Liver Institute , Ipsen Pharmaceuticals Inc , Fibrotic Liver Disease Consortium Investigators , Drug Administration , Newborn Development , Head Of Research , European Medicines Agency , Regulatory Agency , Ipsen Pharmaceuticals , Executive Vice President , New England Journal , Important Safety Information ,

Ipsen Pharma: Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Iqirvo® (elafibranor) 80 mg tablets is the first new medicine approved in nearly a decade for the treatment of the rare liver ....

France General , United States , United Kingdom , Hong Kong , Christelle Huguet , Rachel Reiff , Kris Kowdley , Nicolas Bogler , Anna Gibbins , Amy Wolf , Carol Roberts , Clin Gastroenterol Hepatol , Ipsen Euronext , Ipsen Pharmaceuticals Inc , Regulatory Agency , Liver Institute , Head Of Research , Drug Administration , Fibrotic Liver Disease Consortium Investigators , Ipsen Pharmaceuticals , Newborn Development , European Medicines Agency , Executive Vice President , New England Journal , Important Safety Information , Liver Institute Northwest ,

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a

Ipsen's Iqirvo® receives U.S. FDA accelerated approval as a
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

France General , United States , Hong Kong , United Kingdom , Carol Roberts , Anna Gibbins , Rachel Reiff , Ipsen Euronext , Clin Gastroenterol Hepatol , Nicolas Bogler , Amy Wolf , Christelle Huguet , Kris Kowdley , European Medicines Agency , Ipsen Pharmaceuticals Inc , Fibrotic Liver Disease Consortium Investigators , Ipsen Pharmaceuticals , Newborn Development , Liver Institute , Head Of Research , Drug Administration , Regulatory Agency , Executive Vice President , New England Journal , Important Safety Information , Liver Institute Northwest ,

PSC Partners Announces the First Patient Enrolled Into the WIND-PSC Study, a Global Prospective Cohort to Support the Development of New Treatments for Primary Sclerosing Cholangitis

PSC Partners and PSC Partners Canada, both patient-led non-profit organizations supporting education and research in primary sclerosing cholangitis (PSC), announced today the enrollment of the first patient into the WIND-PSC study. PSC is a rare. ....

Nordrhein Westfalen , United States , Christopher Bowlus , Clin Gastroenterol Hepatol , Bettina Hansen , Gideon Hirschfield , Gulamhuseina Semin , Christoph Schramm , Stephen Rossi , Arbor Research Collaborative For Health , University Of Miami , University Of California , Product Service , Erasmus University , Md University Of Toronto , Data Coordinating Center , Professor Of Medicine At University Miami , Steering Committee , First Patient Enrolled Into , Global Prospective Cohort , New Treatments , Primary Sclerosing , Chief Scientific Officer , Mary Vyas , Cynthia Levy , Arbor Research Collaborative ,

Blood-Based Test Offers Effective Screening Option for Colorectal Cancer

Data from PREEMPT CRC reveal the blood-based screening test demonstrated a 79.2% sensitivity for detecting colorectal cancer. ....

United States , Aasma Shaukat , Clin Gastroenterol Hepatol , Maryh Glickman , American Cancer Society , York University Grossman School Of Medicine , York University Aasma Shaukat , New York University , Digestive Disease Week , New York University Grossman School , African American , Blood Based Screening Test , Early Detection , Gastroenterologists Present Clinical Findings , Med Clin North , Test Increases Colorectal Cancer Screening , Persons Who Declined Colonoscopy , Fecal Immunochemical Test , Randomized Controlled , Clin Gastroenterol ,